Identification of high-risk patients by human epididymis protein 4 levels during follow-up of ovarian cancer

Autor STEFFENSEN, KARINA DAHL, WALDSTRØM, MARIANNE, BRANDSLUND, IVAN, LUND, BENTE, SØRENSEN, SARAH MEJER, PETZOLD, MAX, JAKOBSEN, ANDERS
Vydáno v Oncol Lett (2016)

A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensiti...

Autor Wang, Yun, Herrstedt, Jørn, Havsteen, Hanne, DePoint Christensen, Rene, Mirza, Mansoor Raza, Lund, Bente, Maenpaa, Johanna, Kristensen, Gunnar
Vydáno v BMC Cancer (2014)

Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial

Autor del Campo, Josep M., Matulonis, Ursula A., Malander, Susanne, Provencher, Diane, Mahner, Sven, Follana, Philippe, Waters, Justin, Berek, Jonathan S., Woie, Kathrine, Oza, Amit M., Canzler, Ulrich, Gil-Martin, Marta, Lesoin, Anne, Monk, Bradley J., Lund, Bente, Gilbert, Lucy, Wenham, Robert M., Benigno, Benedict, Arora, Sujata, Hazard, Sebastien J., Mirza, Mansoor R.
Vydáno v J Clin Oncol (2019)